Maria Teresa Majorini

Statistics

Publications

Citations

162

H-Index

Active since

2015

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

University of Coimbra

Candiolo Cancer Institute

University of Turin

International Centre for Genetic Engineering and Biotechnology

Maria Teresa Majorini is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in molecular oncology, medicine, and cancer cell signaling.

ORCID

Publications per year

2015–2020

Publications

Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype

Maria Teresa Majorini, Valeria Cancila, Alice Rigoni et al. · Cancer Research · 2020 · 56 citations · Full text

Medicine, Immunology, Oncology +15

MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner

Francesca Andriani, Maria Teresa Majorini, Miguel Mano et al. · Journal of Hematology & Oncology · 2018 · 36 citations · Full text

Medicine, Cell Biology, Molecular Biology +17

Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members

Annalisa Conti, Maria Teresa Majorini, Enrico Fontanella et al. · Cancer Letters · 2016 · 28 citations

Life Sciences, Cell Biology, Molecular Biology +16

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells

Maria Teresa Majorini, Giacomo Manenti, Miguel Mano et al. · Cell Death and Differentiation · 2018 · 28 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway

Annalisa Conti, Maria Teresa Majorini, Richard Elliott et al. · Oncotarget · 2015 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 5